Management of Chronic Hepatitis B in Special Patient Groups: A Consensus Report of the Study Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology and Infectious Diseases-2023

ArticleAçık Erişim

Özet

Turkish Society of Clinical Microbiology and Infectious Diseases Viral Hepatitis Working Group updated the consensus report on the management of chronic hepatitis B (CHB) in private hosts and special situations. Relevant literature and international guidelines are reviewed, and agreed recommendations are presented at the end of each chapter. In the report, treatment of hepatitis B virus (HBV) and human immunodeficiency virus (HIV) coinfection, management of HBV and hepatitis C virus (HCV) coinfection, management of CHB in severe COVID-19 patients, non-transplant immunocompromised patients.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/17098Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.36519/kd.2023.4684Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorTekin, Sueda
dc.contributor.authorKarakecili, Faruk
dc.contributor.authorBinay, Umut Devrim
dc.contributor.authorCelik, Ilhami
dc.contributor.authorTulek, Necla
dc.contributor.authorTutuncue, Ediz
dc.contributor.authorYildiz, Orhan
dc.contributor.authorYilmaz, Emel
dc.contributor.authorDemirturk, Nese
dc.date.accessioned2026-10-18T20:43:01.542989694Z
dc.date.available2026-10-18T20:43:01.542989694Z
dc.date.issued2023
dc.description.abstractTurkish Society of Clinical Microbiology and Infectious Diseases Viral Hepatitis Working Group updated the consensus report on the management of chronic hepatitis B (CHB) in private hosts and special situations. Relevant literature and international guidelines are reviewed, and agreed recommendations are presented at the end of each chapter. In the report, treatment of hepatitis B virus (HBV) and human immunodeficiency virus (HIV) coinfection, management of HBV and hepatitis C virus (HCV) coinfection, management of CHB in severe COVID-19 patients, non-transplant immunocompromised patients.
dc.identifier.doi10.36519/kd.2023.4684
dc.identifier.eissn1309-1484
dc.identifier.endpage42
dc.identifier.issn1301-143X
dc.identifier.issueÖzel Sayı 1
dc.identifier.startpage23
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/17098
dc.identifier.volume36
dc.identifier.wosWOS:001422246800002
dc.language.isoen
dc.publisherDOC DESIGN & INFORMATICS CO LTD
dc.relation.ispartofKLIMIK JOURNAL
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectChronic hepatitis B
dc.subjectspecial patient groups
dc.subjecttherapy
dc.subjectACUTE LIVER-FAILURE
dc.subjectTENOFOVIR DISOPROXIL FUMARATE
dc.subjectACTING ANTIVIRAL THERAPY
dc.subjectVIRUS INFECTION
dc.subjectC VIRUS
dc.subjectNUCLEOS(T)IDE ANALOGS
dc.subjectLAMIVUDINE TREATMENT
dc.subjectFULMINANT-HEPATITIS
dc.subjectHBV/HCV COINFECTION
dc.subjectADEFOVIR DIPIVOXIL
dc.subjectMedicine, General & Internal
dc.subjectMicrobiology
dc.subjectGeneral & Internal Medicine
dc.titleManagement of Chronic Hepatitis B in Special Patient Groups: A Consensus Report of the Study Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology and Infectious Diseases-2023
dc.typeArticle
dspace.entity.typePublication
rdl.citation.trdizin0
rdl.citation.wos4
rdl.departmentERZİNCAN BİNALİ YILDIRIM ÜNİVERSİTESİ
rdl.departmentT.C. SAĞLIK BAKANLIĞI
rdl.departmentSAĞLIK BİLİMLERİ ÜNİVERSİTESİ
rdl.departmentATILIM ÜNİVERSİTESİ
rdl.departmentAFYONKARAHİSAR SAĞLIK BİLİMLERİ ÜNİVERSİTESİ
rdl.departmentERCİYES ÜNİVERSİTESİ
rdl.departmentKOÇ ÜNİVERSİTESİ
rdl.departmentBURSA ULUDAĞ ÜNİVERSİTESİ
rdl.oa.statusgold
rdl.source.indexWOS
rdl.source.indexTRDIZIN
rdl.wos.indexEmerging Sources Citation Index (ESCI)